苏州麦迪斯顿医疗科技股份有限公司股东减持股份计划公告详细解读

主要内容摘要

• 两位特定股东傅洪、汪建华计划在未来三个月内减持所持有的公司股份。
• 减持总量分别不超过573,978股及533,075股，分别占公司总股本的0.1874%和0.1740%。
• 减持方式为集中竞价及大宗交易，减持时间为2026年3月26日至2026年6月25日。
• 减持原因分别为个人资金需求及偿还债务和改善生活需求。
• 减持股份均为IPO前取得，无一致行动人。
• 股东此前已承诺每年减持不超过持有股份总数的25%，并提前公告。
• 此次减持不会导致公司控制权变更。
• 公司严格遵守相关法律法规及承诺，及时披露信息。

详细解读

苏州麦迪斯顿医疗科技股份有限公司（证券代码：603990，证券简称：麦迪科技）于2026年3月23日发布股东减持股份计划公告，涉及两位特定股东：傅洪和汪建华。两位股东均已不在公司担任任何职务。

减持主体情况

两位股东并非公司控股股东、实控人、一致行动人或公司管理层成员，均为IPO前投资的特定股东。

减持计划具体内容

• 傅洪：计划减持不超过573,978股（占公司总股本0.1874%），减持方式为集中竞价和大宗交易，减持期间为2026年3月26日至2026年6月25日，减持原因是个人资金需求。
• 汪建华：计划减持不超过533,075股（占公司总股本0.1740%），减持方式为集中竞价和大宗交易，减持期间为2026年3月26日至2026年6月25日，减持原因是偿还债务和改善生活需求。
• 如期间公司有送股、资本公积金转增股本等股份变动事项，减持数量将相应调整。
• 若公司股票停牌，减持时间顺延。
• 减持计划实施的最终时间和数量将视市场情况和公司股价决定，存在不确定性。

对投资者的影响及风险提示

• 减持计划符合相关法律法规：公司及股东严格遵守《公司法》、《证券法》及中国证监会、上交所相关规定，无违规减持情况。
• 减持不会导致控制权变更：本次减持比例较低，不会影响公司控制权结构。
• 信息披露及时透明：股东减持前已承诺提前公告，减持比例及方式与此前承诺一致。
• 减持原因：为个人资金需求和偿还债务，非公司经营层面因素。
• 可能影响股价：特定股东减持通常会对市场情绪产生影响，投资者需关注减持进展及市场反应。
• 减持计划存在不确定性：实际减持时间和数量会根据市场情况调整，投资者需关注后续公告。

重要提醒

股东减持行为虽然是个人资金需求或生活改善原因，但短期内大量减持可能对公司股价产生压力。投资者应密切关注公司后续公告及市场动态，审慎评估投资风险。

免责声明

本新闻仅供信息参考，不构成任何投资建议。股东减持计划存在不确定性，投资者需结合自身实际情况和市场动态做出决策。公司及作者不对因本文内容导致的投资损失负责。

English Version

Detailed Analysis of Share Reduction Plan by Shareholders of Suzhou Mediston Medical Technology Co., Ltd.

Key Highlights

• Two specific shareholders, Fu Hong and Wang Jianhua, plan to reduce their holdings within three months.
• The reduction caps are 573,978 shares and 533,075 shares respectively, representing 0.1874% and 0.1740% of the total share capital.
• Reduction methods are block trading and centralized bidding between March 26, 2026 and June 25, 2026.
• The reasons are personal funding needs and debt repayment/improving living conditions.
• Shares to be reduced were acquired pre-IPO, and there are no concerted action persons.
• Shareholders previously committed to annual reduction not exceeding 25% of their holdings and pre-disclosure requirements.
• This reduction will not change the company’s control structure.
• The company adheres strictly to relevant laws, regulations, and disclosure commitments.

In-depth Analysis

Suzhou Mediston Medical Technology Co., Ltd. (Stock Code: 603990) announced on March 23, 2026, that two specific shareholders, Fu Hong and Wang Jianhua, will reduce their shareholdings over the next three months. Both shareholders are no longer serving any positions in the company.

Shareholder Details

The two shareholders are neither controlling shareholders nor senior management, and their shares were acquired before IPO.

Details of Reduction Plan

• Fu Hong: Plans to reduce up to 573,978 shares (0.1874% of total share capital) via block trading and centralized bidding between March 26, 2026 and June 25, 2026. Reason: personal funding needs.
• Wang Jianhua: Plans to reduce up to 533,075 shares (0.1740% of total share capital) via block trading and centralized bidding in the same period. Reason: debt repayment and living improvement.
• If there are stock changes during the reduction period (such as bonus shares or capital increase), the reduction quantity will be adjusted accordingly.
• If trading is suspended, the reduction period will be extended accordingly.
• The actual reduction is subject to market conditions and stock price, and there is uncertainty.

Implications and Risk Reminders for Investors

• Compliance: The plan strictly follows the Company Law, Securities Law, and relevant regulations; there are no violations.
• No Change in Control: The reduction percentages are low and will not affect the control structure.
• Transparent Disclosure: Shareholders have fulfilled advance disclosure commitments; reduction details are consistent with previous promises.
• Reduction Reasons: Driven by personal needs, not company operations.
• Potential Impact on Share Price: Such reductions may influence market sentiment; investors should monitor progress and responses.
• Uncertainty: Actual reduction volume and timing depend on market conditions; further disclosures will follow.

Investor Alert

Although the reduction is for personal funding and debt repayment, significant reductions in a short time can pressure the share price. Investors should closely follow subsequent announcements and market developments and assess risks prudently.

Disclaimer

The news is for informational purposes only and does not constitute investment advice. Reduction plans are subject to uncertainty; investors should make decisions based on their own circumstances and market conditions. Neither the company nor the author is responsible for any investment losses resulting from this content.

View 麦迪科技 Historical chart here